Robert Doebele is the founder of Rain Therapeutics. Rain Therapeutics has raised $140M in total funding. Latest round: IPO. Based in Newark, United States.
Robert Doebele, M.D., Ph.D., is a physician-scientist specializing in precision oncology. He is involved in advancing targeted therapies and clinical trials, including the Phase 3 MANTRA study for milademetan (RAIN-32) at Rain Therapeutics, a clinical-stage biotechnology company.
Full founder directory · Investor directory · Company funding database · Fundraising library